WORLD LEADERS IN DISTINGUISHING PLACEBO FROM ACTIVE IN MEDICAL FOODS AND LIVE THERAPEUTICS
Antimicrobial potential of the human skin microbiota
About the webinar
What can you expect of our webinars?
ON DEMAND WEBINAR | AVAILABLE NOW
Duration: 21 min
Abstract: Join Dr Julie O'Sullivan to understand her research on the area of skin microbiome and how to translate those advancements into final cosmetic products thanks to the validation through human clinical trials. What kind of biomarkers and other considerations to take on board.
DR JULIE O'SULLIVAN | Postdoctoral Researcher, APC Microbiome Ireland, research partner to Atlantia Clinical Trials
Julie O’Sullivan is a postdoctoral researcher with APC Microbiome Ireland at University College Cork in the research group Microbes to Molecules. She recently completed her Ph. D, also with the APC, in Moorepark Food Research Centre, Fermoy, Co. Cork under Prof. Paul Ross, Dr. Mary Rea and Prof. Colin Hill. Her Ph. D research has focused on mining the human skin microbiota for much needed alternatives to antibiotics, primarily antimicrobial peptides called bacteriocins, that exhibit health potential against a wide range of pathogens, including skin pathogens. She is now continuing her research in this area to further explore the gut- skin connection.